1. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification;National Kidney Foundation;Am J Kidney Dis,2002
2. HMG-Coenzyme A reductase inhibitor use is associated with mortality reduction in hemodialysis patients;Mason;Am J Kidney Dis,2005
3. K/DOQI clinical practice guidelines for managing dyslipidemias in chronic kidney disease;Kidney Disease Outcomes Quality Initiative (K/DOQI) group;Am J Kidney Dis,2003
4. Kidney function and anemia as risk factors for coronary heart disease and mortality: The Atherosclerosis Risk in Communities (ARIC) study;Astor;Am Heart J,2006
5. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization;Go;New Engl J Med,2004